1 completed, 1 unknown, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow DNA Repair-Deficiency Disorders: new trials by email Literature Review of DNA Repair-Deficiency Disorders trials Research Report on DNA Repair-Deficiency Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retroviral Insertion Site Methodology Study Strimvelis - Immune System Diseases | Phase 4 | Withdrawn | Fondazione Telethon | 2020-06-25 | 2024-01-29 | |
| Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone Metformin, Pioglitazone - Ataxia-Telangiectasia | Phase 4 | Completed | NHS Tayside | 27 | 2016-09-29 | 2017-12-04 |
| Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT) Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate - Ataxia Telangiectasia, Growth Failure | Phase 4 | Unknown | Johann Wolfgang Goethe University Hospital | 24 | 2010-01-01 | 2010-07-05 |
Ataxia Telangiectasia (2) · Failure to Thrive (1) · Immune System Diseases (1) · Severe Combined Immunodeficiency (1) · Severe combined immunodeficiency due to adenosine deaminase deficiency (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Immunologic Deficiency Syndromes (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Primary Immunodeficiency Diseases (3) · Ataxia (2) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebellar Ataxia (2) · Cerebellar Diseases (2) · Dyskinesias (2) · Immune System Diseases (2)
Clonidine (1) · Estradiol (1) · Growth Hormone (1) · Human Growth Hormone (1) · Metformin (1) · Pioglitazone (1)
Fondazione Telethon (1) · Johann Wolfgang Goethe University Hospital (1) · NHS Tayside (1)
Germany (1) · United Kingdom (1)
Ewan Pearson, MD PhD (1) · Fondazione Telethon (1) · Stefan Zielen, Prof. Dr. (1)